Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143442
Status:
COMPLETED
Last Update Posted:
2006-08-08
First Post:
2005-09-01
Brief Title:
Study of SS-Reboxetine in Patients With Postherpetic Neuralgia Who Are Gabapentin Treatment Failures
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A 5-Week Randomized Double-Blind Placebo-Controlled Multi-Center Study Of SS-Reboxetine In Patients With Postherpetic Neuralgia PHN Who Are Gabapentin Treatment Failures
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effectiveness of SS-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None